
Howard M Belmont MD
Lupus & Related, Scleroderma & Related, Vasculitis
Professor, Medicine, New York University School of Medicine
Join to view full profile
333 E 38th St# NyuNew York, NY 10016
Phone+1 646-501-7400
Fax+1 646-501-7228
Dr. Belmont is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineFellowship, Rheumatology, 1983 - 1984
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1980 - 1983
University of Pittsburgh School of MedicineClass of 1980
Harvard UniversityBA, Cum Laude, 1976
Certifications & Licensure
NY State Medical License 1981 - 2027
FL State Medical License 2014 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- Correlation of Hydroxychloroquine Whole Blood Levels With Real and Ideal Body Weight Dosing and Development of Retinal Toxicity.Alexis Kaiser, Joseph Colcombe, Lucy Cobbs, Emily Gutowski, Jill Buyon
Journal of Vitreoretinal Diseases. 2026-08-06 - 1 citationsInduction treatment of lupus nephritis: to pulse or not to pulse? Whether 'tis nobler to universally or selectively prescribe.Emily Gutowski, Howard Michael Belmont
Lupus Science & Medicine. 2026-02-15 - 5 citationsLow versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials.Amit Saxena, Cristina Sorrento, Peter Izmirly, Janine Sullivan, Monica Gamez-Perez
Lupus Science & Medicine. 2025-01-06
Journal Articles
- Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
- Anal squamous cell carcinoma in two intravenous cyclophosphamide treated systemic lupus patients with human papilloma virus infectionLydon EJ, Belmont HM, Lydon EJ, Belmont HM, 7/26/2013
- Treatment of Systemic Lupus Erythematosus:2013Belmont HM, Update Bulletin of NYU Hospital for Joint Diseases, 1/1/2013
Books/Book Chapters
Abstracts/Posters
- Long term follow-up of AVN natural history in cohort of SLE patients randomized to atorvostatin during high dose treatmentLydon E, Belmont HM, Arthritis and Rheumatism, 1/1/2013
- Favorable response to belimumab at three monthsShum K, Buyon JP, Belmont HM, Askanese A, Arthritis and Rheumatism, 1/1/2012
- HPV as a Risk Factor for Perianal Squamous Cell Carcinoma in Systemic Lupus ErythematosusLydon E, Belmont HM, Arthritis and Rheumatism, 1/1/2010
Grant Support
- Clinical Trial: Lipitor To Prevent Avascular Necrosis In Systemic Lupus ErythemaNational Center For Research Resources2008
- Lipitor To Prevent Avascular Necrosis In Systemic Lupus ErythematosusNational Center For Research Resources2004–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









